The sale was valued at approximately $847,000.
The disposition represented 3% of the insider's total direct equity holdings in the company.
The 5,994 shares were sold on Aug. 14 and Aug. 17.
Vernon Rogers, Exec VP of Sales & Mktg. at Aehr Test Systems(NASDAQ:AEHR), sold 5,994 shares of common stock at $141.34 per share, according to a recent SEC Form 4 filing.
| Metric | Value |
|---|---|
| Shares sold (directly held) | 5,994 |
| Transaction value | $847,192 |
| Post-transaction shares (directly held) | 186,232 |
| Post-transaction value | $27.1 million |
Transaction value based on SEC Form 4 weighted average sale price ($141.34); post-transaction value based on Aug. 17, 2026, market close ($145.61).
| Metric | Value |
|---|---|
| Share Price (as of market close 2026-08-17) | $145.61 |
| Market Capitalization | $2.5 billion |
| Revenue (TTM) | $50 million |
| Net Income (TTM) | -$7.1 million |
Aehr Test Systems, founded in 1977 and headquartered in Fremont, California, is a specialized provider of critical test and burn-in equipment for the semiconductor industry. The company employs 138 people and maintains a focused market position serving semiconductor manufacturers that require advanced validation solutions for integrated circuits. With a market capitalization of $2.5 billion as of Aug. 31, 2026, Aehr has demonstrated significant investor interest in its specialized semiconductor test equipment offerings. However, the company remains in a pre-profitability phase with TTM net losses of $7.1 million against TTM revenues of $50 million.
Aehr Test Systems is at the right place at the right time for the artificial intelligence (AI) boom. According to Statista, the global AI market is expected to reach $617.6 billion in value in 2026 and $1.4 trillion by 2032. Demand is showing up in the company's earnings, as it reported $18.8 million in net revenue for its fiscal four quarter of 2026, an increase from the $14.1 million reported in the year-ago period. Aehr also reported net income of $1.4 million for the quarter, a notable improvement over the $2.9 million net loss from the fourth quarter of 2025. Bookings also hit a record $60.7 million for the quarter, and as of May 29, Aehr Test Systems has a backlog of $80.6 million.
Just thus far in 2026, the stock price has climbed 291.4%. In comparison, the S&P 500 is up 12.1% in the same period. With that context in mind, and given the nearly 6,000 shares sold Rogers sold, this transaction appears to be largely a routine sale. This is likely a situation of the executive just taking some profits off the table, as he still owns 186,232 worth of stock. If more shares were sold, that might be more noteworthy, but for shareholders, this doesn't appear to signal any concern about the company's future.
Before you buy stock in Aehr Test Systems, consider this:
The Motley Fool Stock Advisor analyst team just identified what they believe are the 10 best stocks for investors to buy now… and Aehr Test Systems wasn’t one of them. The 10 stocks that made the cut could produce monster returns in the coming years.
Consider when Netflix made this list on December 17, 2004... if you invested $1,000 at the time of our recommendation, you’d have $440,710!* Or when Nvidia made this list on April 15, 2005... if you invested $1,000 at the time of our recommendation, you’d have $1,335,252!*
Now, it’s worth noting Stock Advisor’s total average return is 978% — a market-crushing outperformance compared to 213% for the S&P 500. Don't miss the latest top 10 list, available with Stock Advisor, and join an investing community built by individual investors for individual investors.
See the 10 stocks »
*Stock Advisor returns as of August 31, 2026.
Jack Delaney has no position in any of the stocks mentioned. The Motley Fool has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy.